Cc1cc(C)n(-c2nc3cc(Cl)ccc3nc2N2CCN(c3cccc(C)c3C)CC2)n1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?